Low anti‐Rh D I g G‐Fc‐fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Summary: Haemolytic disease of the fetus and newborn (HDFN) may occur when maternal I g G antibodies against red blood cells (RBC s), often anti‐R h D (anti‐D) antibodies, cross the placenta and mediate the destruction of RBC s via phagocytic I g G‐F c‐receptors (F cγ R). Clinical severity is not strictly related to titre and is more accurately predicted by the diagnostically‐applied monocyte‐based antibody‐dependent cellular cytotoxicity (ADCC), a sensitive test with relatively low specificity. This suggests that other factors are involved in the pathogenesis of HDFN. Binding of I g G to F cγ R requires the N‐linked glycan at position 297 in the I g G‐F c‐region, consisting of several different glycoforms. We therefore systematically analysed I g G‐derived glycopeptides by mass spectrometry from 70 anti‐D I g G 1 antibodies purified from the plasma of alloimmunized pregnant women. This revealed a variable decrease in F c‐fucosylation in the majority of anti‐D I g G 1 (even down to 12%), whereas the total I g G of these patients remained highly fucosylated, like in healthy individuals (>90%). The degree of anti‐D fucosylation correlated significantly with CD 16 (F cγ RIII a)‐mediated ADCC, in agreement with increased affinity of defucosylated I g G to human F cγ RIII a. Additionally, low anti‐D fucosylation correlated significantly with low fetal‐neonatal haemoglobin levels, thus with increased haemolysis, suggesting I g G‐fucosylation to be an important pathological feature in HDFN with diagnostic potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754
Parekh, R. B., Dwek, R. A., Sutton, B. J., Fernandes, D. L., Leung, A., Stanworth, D., Rademacher, T. W., Mizuochi, T., Taniguchi, T., Matsuta, K., et al. (1985) · Nature · doi:10.1038/316452a0 · Cited by 1,170
Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc
Anthony, R. M., Nimmerjahn, F., Ashline, D. J., Reinhold, V. N., Paulson, J. C., & Ravetch, J. V. (2008) · Science · doi:10.1126/science.1154315 · Cited by 849 · cited 1×
“…[where we found that increased galactosylation generally resulted in increased sialylation, given that the substrate for sialyltransferases (adding a2-6 sialic acid) are b1,4 galactose residues (Anthony et al, 2008)], a similar increase in sialylation of the anti-D specific IgG1 was expected.”
BackgroundFerrara, C., Grau, S., Jäger, C., Sondermann, P., Brünker, P., Waldhauer, I., Hennig, M., Ruf, A., Rufer, A. C., Stihle, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108455108 · Cited by 770
Stapleton, N. M., Andersen, J. T., Stemerding, A. M., Bjarnarson, S. P., Verheul, R. C., Gerritsen, J., Zhao, Y., Kleijer, M., Sandlie, I., de Haas, M., et al. (2011) · Nature Communications · doi:10.1038/ncomms1608 · Cited by 286 · cited 2×
“For calculations of IgG1 and IgG3 concentrations, fully human recombinant antibodies IgG1j and IgG3 GDob1 (Vidarsson et al, 2006; Stapleton et al, 2011) were used as standards.”
BackgroundMethodSelf-citationComparison of the Fc glycosylation of fetal and maternal immunoglobulin G
Einarsdottir, H. K., Selman, M. H. J., Kapur, R., Scherjon, S., Koeleman, C. A. M., Deelder, A. M., van der Schoot, C. E., Vidarsson, G., & Wuhrer, M. (2013) · Glycoconjugate Journal · doi:10.1007/s10719-012-9381-6 · Cited by 94
Self-citation
Cited by
IgG Subclasses and Allotypes: From Structure to Effector Functions
Vidarsson, G., Dekkers, G., & Rispens, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00520 · Cited by 2,667
“In several health and disease settings, a shift toward certain Faband Fc-glycoforms of antibodies has been reported (54, 55, 103).”
BackgroundInfluentialSelf-citationAfucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity
Larsen, M. D., de Graaf, E. L., Sonneveld, M. E., Plomp, H. R., Nouta, J., Hoepel, W., Chen, H.-J., Linty, F., Visser, R., Brinkhaus, M., et al. (2021) · Science · doi:10.1126/science.abc8378 · Cited by 408
“The large difference in the number of antigen-specific afucosylated responses observed between patients contributes to the variability of disease severity, as has been shown for neonatal alloimmune cytopenias (12, 13, 17) and dengue (15).”
BackgroundSelf-citationImmunoglobulin G glycosylation in aging and diseases
Gudelj, I., Lauc, G., & Pezer, M. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.07.009 · Cited by 408
Dekkers, G., Treffers, L., Plomp, R., Bentlage, A. E. H., de Boer, M., Koeleman, C. A. M., Lissenberg-Thunnissen, S. N., Visser, R., Brouwer, M., Mok, J. Y., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00877 · Cited by 356
Self-citationHarvey, D. J. (2018) · Mass Spectrometry Reviews · doi:10.1002/mas.21530 · Cited by 61
Metadata
- Authors
- Kapur, R., Della Valle, L., Sonneveld, M., Hipgrave Ederveen, A., Visser, R., Ligthart, P., de Haas, M., Wuhrer, M., van der Schoot, C. E., & Vidarsson, G.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2014-06-07
- Volume
- 166
- Issue
- 6
- Pages
- 936-945
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2034498773
- Cited by
- 128
- References
- 7
- FWCI
- 5.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.